Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Weinstein, Aviv M., Paola Rosca, Liana Fattore, and Edythe D. London. "Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health." Frontiers in psychiatry 8 (2017): 156. |
|
Guitter, Marie, Vincent Laprevote, Adrian Lala, Livia Sturzu, Daniela Dobre, and Raymund Schwan. "Rate and predictors of interrupted patient follow?up after first?episode psychosis?a retrospective cohort study in France." Early Intervention in Psychiatry (2020). |
|
Beckwith, Deborah, Lynne Briggs, Margaret Shapiro, and Angel Carrasco. "Engaging young people in early psychosis services–a challenge for social work." Social Work in Mental Health 19, no. 2 (2021): 105-125. |
|
Simon, Frederick AJ, Maria Schenk, Denise Palm, Frank Faltraco, and Johannes Thome. "The Collateral Damage of the COVID-19 Outbreak on Mental Health and Psychiatry." International Journal of Environmental Research and Public Health 18, no. 9 (2021): 4440. |
|
Goldsmith, David R., and Mark Hyman Rapaport. "Inflammation and negative symptoms of schizophrenia: implications for reward processing and motivational deficits." Frontiers in psychiatry 11 (2020): 46. |
|
Seeman, Philip, and Mary V. Seeman. "Schizophrenia and the supersensitive synapse." Neuropsychiatry 1, no. 3 (2011): 233-42. |
|
Alnaas, Aml A., Carrie L. Moon, Mitchell Alton, Scott M. Reed, and Michelle K. Knowles. "Conformational changes in C-reactive protein affect binding to curved membranes in a lipid bilayer model of the apoptotic cell surface." The Journal of Physical Chemistry B 121, no. 12 (2017): 2631-2639. |
|
Liu, Liang, Yin Luo, Guofu Zhang, Chunhui Jin, Zhenhe Zhou, Zaohuo Cheng, and Guozhen Yuan. "The mRNA expression of DRD2, PI3KCB, and AKT1 in the blood of acute schizophrenia patients." Psychiatry research 243 (2016): 397-402. |
|
Zhuo, Chuanjun, Yong Xu, Li Zhang, Rixing Jing, and Chunhua Zhou. "The effect of dopamine antagonist treatment on auditory verbal hallucinations in healthy individuals is clearly influenced by comt genotype and accompanied by corresponding brain structural and functional alterations: an artificially controlled pilot study." Frontiers in genetics 10 (2019): 92. |
|
Ericksen, Spencer S., David F. Cummings, Michael E. Teer, Shahnawaz Amdani, and John A. Schetz. "Ring substituents on substituted benzamide ligands indirectly mediate interactions with position 7.39 of transmembrane helix 7 of the D4 dopamine receptor." Journal of Pharmacology and Experimental Therapeutics 342, no. 2 (2012): 472-485. |
|
Powell, Anna-Leigh, Cassandra Hinger, Erica D. Marshall-Lee, Tonya Miller-Roberts, and Kayla Phillips. "Implementing coordinated specialty care for first episode psychosis: A review of barriers and solutions." Community Mental Health Journal 57 (2021): 268-276. |
|
Boozalis, Ted, Antonio L. Teixeira, Raymond Young-Jin Cho, and Olaoluwa Okusaga. "C-reactive protein correlates with negative symptoms in patients with schizophrenia." Frontiers in public health 5 (2018): 360. |
|
Tonin, Fernanda S., Astrid Wiens, Fernando Fernandez-Llimos, and Roberto Pontarolo. "Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy." Core evidence 11 (2016): 49. |
|
Quidé, Yann, Chiara C. Bortolasci, Briana Spolding, Srisaiyini Kidnapillai, Oliver J. Watkeys, Sarah Cohen-Woods, Michael Berk, Vaughan J. Carr, Ken Walder, and Melissa J. Green. "Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder." Psychological medicine 49, no. 16 (2019): 2736-2744. |
|
Dempsey, Charles, Cameron Quanbeck, Clarissa Bush, and Kelly Kruger. "Decriminalizing mental illness: specialized policing responses." CNS spectrums 25, no. 2 (2020): 181-195. |
|
Zheng, Fenglian, Chuntong Li, Dongsheng Zhang, Dong Cui, Zhipeng Wang, and Jianfeng Qiu. "Study on the sub-regions volume of hippocampus and amygdala in schizophrenia." Quantitative imaging in medicine and surgery 9, no. 6 (2019): 1025. |
|
Nalbant, Ahmet, Aylin Can, Huseyin Sehid Burhan, Alparslan Cansiz, Kas?m Fatih Yavuz, Mehtap Arslan Delice, and Erhan Kurt. "Tardive dyskinesia in long term hospitalized patients with schizophrenia." Dusunen Adam The Journal of Psychiatry and Neurological Sciences 29, no. 3 (2016): 259. |
|
Song, Jinuk, Doug Hyun Han, Sun Mi Kim, Ji Sun Hong, Kyung Joon Min, Jae Hoon Cheong, and Bung Nyun Kim. "Differences in gray matter volume corresponding to delusion and hallucination in patients with schizophrenia compared with patients who have bipolar disorder." Neuropsychiatric Disease and Treatment 11 (2015): 1211. |
|
Laferrière-Simard, Marie-Christine, Tania Lecomte, and Lola Ahoundova. "Empirical testing of criteria for dissociative schizophrenia." Journal of Trauma & Dissociation 15, no. 1 (2014): 91-107. |
|
Ochoa, S., R. López-Carrilero, M. L. Barrigón, E. Pousa, A. Barajas, E. Lorente-Rovira, F. González-Higueras et al. "Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis." Psychological Medicine 47, no. 9 (2017): 1573-1584. |
|